Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03004937 · ClinicalTrials.gov registry record · NA

Early Auditory Referral in Primary Care

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
10,000
Enrollment target

NCT03004937 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 10,000 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03004937, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
10,000 participants
Enrollment target

Study Summary

Busy Primary Care providers (PCPs) have complex practices with many competing demands, making it difficult to improve their HL identification rates. Little research has been conducted to identify effective approaches to address the poor PCP knowledge and provide tools for them to better identify/refer patients with HL for appropriate intervention. Current data suggests there is a critical need to redesign how PCPs deliver hearing health care (HHC) by developing focused educational programs and simple clinical management tools to help them integrate HHC into their practices. To address this need, this study will educate providers on hearing loss (HL) screening/treatment as well as create a Best Practice Alert (BPA), or clinical prompt, that is configured for maximal effectiveness in reminding PCPs to ask their patients if they think they have a HL. This combination of education for providers and clinical reminder could help increase HL screening rates but how much is not clear. This 5 year R21/R33 study funded by National Institute of Deafness and Communicative Disorders seeks to provide detailed understanding of both how educating providers on HL and the use of an effective BPA affects HL screening rates and identification for people with mild to moderate hearing loss.

Interventions

  • OTHER Family Medicine Hearing Loss Best Practice Alert

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2014-04
Est. Completion 2019-03-31
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03004937

The ClinicalTrials.gov registry entry for NCT03004937 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Family Medicine Hearing Loss Best Practice Alert is the first listed.

NCT03004937 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03004937 about?

NCT03004937 is a clinical study titled "Early Auditory Referral in Primary Care". Busy Primary Care providers (PCPs) have complex practices with many competing demands, making it difficult to improve their HL identification rates. Little research has been conducted to identify effective approaches to address the poor PCP knowledge and provide tools for them to better identify/ref...

What is the current status of trial NCT03004937?

This trial is currently completed. It is a NA study. The enrollment target is 10,000 participants. The study started on 2014-04. Estimated completion is 2019-03-31.

What interventions are being tested in trial NCT03004937?

The interventions under investigation include: Family Medicine Hearing Loss Best Practice Alert (OTHER).

Who is sponsoring clinical trial NCT03004937?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.